| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000041137 |
| Receipt No. | R000046907 |
| Scientific Title | Investigation of the efficacy by modified thoracoabdominal nerves block perichondrial approach (M-TAPA) in radical hysterectomy : a pilot study |
| Date of disclosure of the study information | 2020/07/17 |
| Last modified on | 2022/04/27 (Ver. 6) |
| Basic information | ||
| Public title | Investigation of the efficacy by modified thoracoabdominal nerves block perichondrial approach (M-TAPA) in radical hysterectomy : a pilot study | |
| Acronym | Investigation of the efficacy by modified thoracoabdominal nerves block perichondrial approach (M-TAPA) in radical hysterectomy : a pilot study | |
| Scientific Title | Investigation of the efficacy by modified thoracoabdominal nerves block perichondrial approach (M-TAPA) in radical hysterectomy : a pilot study | |
| Scientific Title:Acronym | M-TAPA in radical hysterectomy | |
| Region |
|
|
| Condition | ||
| Condition | Gynecologic malignancies for which radical hysterectomy is indicated | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Epidural anesthesia (analgesia) has been the main means of analgesia for a wide range of surgical wounds in abdominal surgery. However, removal of epidural catheter may occur epidural hematoma because anticoagulation therapy is performed in early stage at post operative period. Hence, the need for epidural anesthesia (analgesia) is swaying due to the risk and the rise of ultrasound-guided nerve block.
Tulgar et al. reported the efficacy of modified thoracoabdominal nerves block perichondrial approach (M-TAPA). M-TAPA may provide analgesia for somatic pain in Th7-Th11. However, the efficacy of M-TAPA is reported in case reports, especially in laparoscopic surgery. This is the prospective observational study (a pilot study) to evaluate the efficacy of M-TAPA in open abdominal surgery. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluation of anesthetized dermatomal range by M-TAPA at 2 and 24 hours after surgery |
| Key secondary outcomes | Numerical rating scale (NRS) at 2/24/48 hours after surgery
Opioid consumption after surgery Frequency of non-opioid analgesic use Occurrence of postoperative nausea and vomiting |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Scheduled radical hysterectomy undergoing M-TAPA in addition to general anesthesia at Nara Medical University Hospital.
|
|||
| Key exclusion criteria | Rejection
Communication difficulty Chronic opioid use (Daily use or usage morphine equivalent more than 60mg per day within 1 month before surgery) Skin disease at puncture site History of previous surgery at abdomen Allergy to local anesthetics Coagulation disorder Patients who have received antithrombotic therapy and conflict with a sufficient period of drug withdrawal according to the guideline published by JSA/JSRA/JSPC Body weight < 45 kg BMI > 35 Visit restrictions due to prevention for COVID-19 Judged inappropriate by the investigator |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nara Medical University | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | 634-8521 | ||||||
| Address | 840 Shijyo-cho, Kashihara, Nara | ||||||
| TEL | 0744-22-3051 | ||||||
| nobuhirotanaka@naramed-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nara Medical University | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | 634-8521 | ||||||
| Address | 840 Shijyo-cho, Kashihara, Nara | ||||||
| TEL | 0744-22-3051 | ||||||
| Homepage URL | |||||||
| nobuhirotanaka@naramed-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Anesthesiology, Nara Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nara Medical University Hospital Institutional Review Board. |
| Address | 840 Shijyo-cho, Kashihara, Nara |
| Tel | 0744-22-3051 |
| ino_rinri@naramed-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://bmcanesthesiol.biomedcentral.com/articles/10.1186/s12871-022-01652-2 | ||||||
| Number of participants that the trial has enrolled | 10 | ||||||
| Results | The median numbers (interquartile range) of anesthetized dermatomes at 2 and 24 h postoperatively were 6 (5-7) and 6.5 (5-7) in the anterior cutaneous branch area and 5 (4-7) and 7 (5-7) in the lateral cutaneous branch area, respectively. There was an 85% chance of simultaneously acquiring analgesia in areas innervated by Th8-11, including complete block in areas innervated by the anterior cutaneous branches of Th9-10. | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Observational Study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046907 |